Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 17,629 | 10,003 | 4,045 | 0 | 0 |
| Operating Income | -17,629 | -10,003 | -4,045 | N/A | N/A |
| Other Income | 7 | 10 | 57 | 0 | 0 |
| Pre-tax Income | -17,622 | -9,993 | -3,988 | 0 | 0 |
| Net Income Continuous | -17,622 | -9,993 | -3,988 | N/A | N/A |
| Net Income | $-17,622 | $-9,993 | $-3,988 | $N/A | $N/A |
| EPS Basic Total Ops | -1.74 | -0.99 | -0.40 | N/A | N/A |
| EPS Basic Continuous Ops | -1.74 | -0.99 | -0.40 | N/A | N/A |
| EPS Diluted Total Ops | -1.74 | -0.99 | -0.40 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.74 | -0.99 | -0.40 | N/A | N/A |
| EBITDA(a) | $-17,624 | $-9,999 | $-4,041 | $N/A | $N/A |